These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11309352)

  • 1. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.
    Li M; Wu X; Xu XC
    Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
    Li M; Wu X; Xu XC
    Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.
    Sánchez-Alcázar JA; Bradbury DA; Pang L; Knox AJ
    Lung Cancer; 2003 Apr; 40(1):33-44. PubMed ID: 12660005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage.
    Wikström K; Juhas M; Sjölander A
    Biochem J; 2003 Apr; 371(Pt 1):115-24. PubMed ID: 12482325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells.
    Chang HC; Weng CF
    Oncol Rep; 2001; 8(6):1321-5. PubMed ID: 11605058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of chemotherapeutic drug-induced apoptosis by a cyclooxygenase-2 inhibitor in hypopharyngeal carcinoma cells.
    Peng JP; Liu LT; Chang HC; Hung WC
    Cancer Lett; 2003 Nov; 201(2):157-63. PubMed ID: 14607329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
    Liu XH; Yao S; Kirschenbaum A; Levine AC
    Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
    Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G; Schulze-Osthoff K; Jänicke RU
    Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.
    Honjo S; Osaki M; Ardyanto TD; Hiramatsu T; Maeta N; Ito H
    DNA Cell Biol; 2005 Mar; 24(3):141-7. PubMed ID: 15767780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.
    Ding H; Han C; Zhu J; Chen CS; D'Ambrosio SM
    Int J Cancer; 2005 Feb; 113(5):803-10. PubMed ID: 15499625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
    Jendrossek V; Handrick R; Belka C
    FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.
    Munkarah AR; Genhai Z; Morris R; Baker VV; Deppe G; Diamond MP; Saed GM
    Gynecol Oncol; 2003 Mar; 88(3):429-33. PubMed ID: 12648598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.